JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB267288

Human MAP3K10 (MLK2) knockout HEK-293T cell line

Be the first to review this product! Submit a review

|

(0 Publication)

MAP3K10 KO cell line available to order. KO validated by. Free of charge wild type control provided. Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon 1 and 8 bp deletion in exon 1.

View Alternative Names

M3K10_HUMAN, MAP3K 10, MEKK10, MKN28 derived nonreceptor type serine/threonine kinase, MKN28 kinase, Mitogen-activated protein kinase kinase kinase 10, Mixed lineage kinase 2, Protein kinase MST

2 Images
Sanger Sequencing - Human MAP3K10 (MLK2) knockout HEK-293T cell line (AB267288)
  • Sanger seq

Unknown

Sanger Sequencing - Human MAP3K10 (MLK2) knockout HEK-293T cell line (AB267288)

Allele-1 : 8 bp deletion in exon1

Sanger Sequencing - Human MAP3K10 (MLK2) knockout HEK-293T cell line (AB267288)
  • Sanger seq

Unknown

Sanger Sequencing - Human MAP3K10 (MLK2) knockout HEK-293T cell line (AB267288)

Allele-2 : 1 bp insertion in exon 1.

Key facts

Cell type

HEK-293T

Species or organism

Human

Tissue

Kidney

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon 1 and 8 bp deletion in exon 1

Product details

Recommended control: Human wild-type HEK293T cell line (ab255449). Please note a wild-type cell line is not automatically included with a knockout cell line order, if required please add recommended wild-type cell line at no additional cost using the code WILDTYPE-TMTK1.

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab267288-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab267288 Human MAP3K10 (MLK2) knockout HEK-293T cell line", "number":"AB267288-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab267288-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab267288 Human MAP3K10 (MLK2) knockout HEK-293T cell line", "number":"AB267288-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
MAP3K10
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The MLK2 protein also known as MAP3K10 (Mitogen-Activated Protein Kinase Kinase Kinase 10) plays a role as a serine/threonine kinase. It weighs around 95 kDa and affects multiple intracellular signaling pathways. It is expressed in numerous tissues including the brain placenta and kidney. MLK2 features a catalytic domain typical of MAP3 kinases and a CRIB domain that interacts with small GTPases.
Biological function summary

This kinase influences cellular dynamics by partaking in the MAP kinase signal transduction cascade and is a component of signaling complexes. MLK2 is important in the regulation of cell proliferation differentiation and apoptosis. It primarily transduces signals originating from cell surface receptors through multi-step phosphorylation events affecting downstream effectors. MLK2 interacts with MAP kinase kinases (MKKs) to activate c-Jun N-terminal kinases (JNKs) and p38 pathways.

Pathways

MLK2 acts within the MAPK signaling and JNK pathways. It regulates responses to environmental stresses and cytokines therefore modulating cell fate. MLK2 has functional associations with proteins like JNKs and MKKs which play leading roles in these pathways. Furthermore it works in conjunction with other MAP3Ks to regulate MAPK signaling cascades tightly.

MLK2 shows associations with neurodegenerative diseases and cancer. Dysregulation of MLK2 kinase activity can contribute to the pathophysiology of Alzheimer's disease by affecting neuronal survival pathways. In various cancers altered MLK2 expression or function may lead to abnormal cell growth. These conditions often involve connections with proteins such as JNKs which are implicated in cellular stress responses and apoptotic pathways.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com